Advertisement

Topics

Groupe LTI Company Profile

00:42 EST 24th November 2017 | BioPortfolio

Nil

Location

190 rue Centre
Magog
Quebec
J1X 5P8
Canada

Contact

Phone: (819) 843-3443
Fax: (819) 843-6241
Email: Info@groupelti.com


News Articles [15 Associated News Articles listed on BioPortfolio]

Le Groupe Jean Coutu : R?sultats du premier trimestre de l'exercice financier 2018

11 juil. 2017 07h00 HE VARENNES, QUÉBEC--(Marketwired - 11 juillet 2017) -Le Groupe Jean Coutu (PJC) inc. (TSX:PJC.A) (la « Société » ou le Read more...

Appel conf?rence du Groupe Jean Coutu : R?sultats du premier trimestre de l'exercice financier 2018

Appel conférence du Groupe Jean Coutu : Résultats du premier trimestre de l'exercice financier 2018 Read more...

VALNEVA annonce le succès de son Assemblée Générale et la nomination de deux nouveaux membres à son Conseil de Surveillance

VALNEVA — Friday, June 30th 2017 at 5:00am UTC Valneva annonce le succès de son Assemblée Générale et la nomination de deux nouveaux membres à son Conseil de Surveillance; Le Groupe confirm...

Mondelez International names new CEO

David SalazarDirk Van de Put, who currently leads Canadian frozen foods giant McCain Foods,  has previously held executive positions with Novartis, Groupe Danone, Coca-Cola and Mars. read mo...

Sebbin's Statement on Anaplastic Large Cell Lymphoma (ALCL) & Breast Implants

BOISSY L’AILLERIE, France, September 20, 2017 /PRNewswire/ -- Anaplastic Large Cell Lymphoma (ALCL) is a malignant disease affecting the lymphatic system. Although it is a very rare condition, e...

15H : les infos biotechs qui font le buzz

Oncodesign  (ALONC). Le chiffre d’affaires du groupe stable à fin juin 2017 v/s 1er semestre 2016 ; la croissance des revenus de Service (+9,7% à 5,3 M€) compense le retrait des revenus de Part...

15H30 le point du jour avec Biotech Finances

Jean-Pierre Loza, prend la direction de l’équipe d’analystes Sciences du vivant au sein d’Aurgalys. Jean-Pierre Loza est Docteur en sciences et diplômé en biochimie de l’UTC Co...

Mercatobiotech : Joël Richard chez GlioCure et Werner Rein chez Theranexux

Tous les jours un bref écho des principales infos de la veille avec le remindHIER de BiotechFinances Joël Richard, Vice-Président Senior Développement Peptides du groupe Ipsen, spécialiste inter...

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Collective publication. Panel proposal for the immunophenotypic diagnosis of hematological malignancies. A collaborative consensus from the Groupe d'Etude Immunologique des Leucémies (GEIL).

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

For early-stage Hodgkin lymphoma (HL), optimal chemotherapy regimen and the number of cycles to be delivered remain to settle down. The H9-U trial compared three modalities of chemotherapy followed by...

Is the Choosing Wisely(®) campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study.

Launched in the US in 2012, Choosing Wisely(®) is a campaign promoted by the American Board of Internal Medicine (ABIM) Foundation with the goal of improving healthcare effectiveness by avoiding wast...

In Praise of Sociology.

This reflection on the relevance of sociology starts with the different forms of social knowledge, and some autobiographical reflection on my engagement with the discipline. A research-based social sc...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

The Healthy Options Feasibility Study

The investigators hypothesize that having health care providers other than physicians within a "Groupe de Médecine de Famille" conduct cardiovascular risk assessments and teach lifestyle ...

Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial

This multicenter, randomized, controlled trial was conducted by the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID) to evaluate the efficacy and safet...

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

The main objective of the study is to improve outcome of younger patients (between 18-60 years) with acute myeloid leukemia and intermediate risk defined by the cytogenetics. In this popul...

The Intra-Aortic Balloon Pumps Insertion Registry on Behalf of the Groupe Des Angioplasticiens de la Région Ouest

Intra-aortic Balloon Pumps (IABP) have been used for roughly 50 years in Critical Care Units, Intensive Care Units, Cath labs as a way to improve systemic and coronary circulation in patie...

Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)

Behavioural disorders are very common right from the initial stage of dementia and contribute to loss of autonomy. Behavioural dysexecutive disorders have a particular status due to their ...

Companies [31 Associated Companies listed on BioPortfolio]

Groupe SEB

The world leader in small domestic equipment, Groupe SEB operates in more than 120 countries with a unique portfolio of top brands marketed through multi-format retailing. Selling some 170 million pro...

GFI Informatique

GFI Informatique est une Société Anonyme de droit français à Conseil d'Administration, régie par la loi du 24 juillet 1966, au capital de 92 679 204 euros.Le titre est coté au premier marché d'...

GROUPE IDI

Le Groupe IDI, pionnier du capital investissement, est l'un des principaux intervenants indépendants du métier.Créé en 1970 par les Pouvoirs Publics pour apporter des fonds propres aux PME , l’I...

Publicis Groupe Services

Publicis Groupe [Euronext Paris: FR0000130577] is the world's third largest communications group. In addition, it is ranked as the world's second largest media counsel and buying group, and is the...

Groupe Athena Inc.

Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical a...

More Information about "Groupe LTI" on BioPortfolio

We have published hundreds of Groupe LTI news stories on BioPortfolio along with dozens of Groupe LTI Clinical Trials and PubMed Articles about Groupe LTI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Groupe LTI Companies in our database. You can also find out about relevant Groupe LTI Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record